CINECA IRIS Institutional Research Information System

BALDOVINO, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.642
EU - Europa 5.477
AS - Asia 3.413
SA - Sud America 752
AF - Africa 134
OC - Oceania 95
Continente sconosciuto - Info sul continente non disponibili 22
Totale 18.535
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.157
IT - Italia 1.775
CN - Cina 1.379
DE - Germania 474
FR - Francia 474
SG - Singapore 407
IE - Irlanda 405
JP - Giappone 386
ES - Italia 379
GB - Regno Unito 333
MX - Messico 300
SE - Svezia 297
BR - Brasile 234
IN - India 217
FI - Finlandia 212
UA - Ucraina 205
CO - Colombia 193
KR - Corea 188
CA - Canada 148
VN - Vietnam 147
TR - Turchia 139
PL - Polonia 129
ID - Indonesia 123
AR - Argentina 98
GR - Grecia 93
AT - Austria 91
RU - Federazione Russa 91
NL - Olanda 85
AU - Australia 84
CH - Svizzera 82
CL - Cile 74
PT - Portogallo 74
TW - Taiwan 66
SA - Arabia Saudita 61
PE - Perù 55
RO - Romania 55
HK - Hong Kong 53
EC - Ecuador 47
TH - Thailandia 47
BE - Belgio 46
IL - Israele 45
IR - Iran 40
EG - Egitto 33
VE - Venezuela 32
SI - Slovenia 29
CZ - Repubblica Ceca 24
PK - Pakistan 22
EU - Europa 21
RS - Serbia 21
NO - Norvegia 19
ZA - Sudafrica 19
PH - Filippine 18
DZ - Algeria 17
TN - Tunisia 17
AE - Emirati Arabi Uniti 15
HU - Ungheria 14
NG - Nigeria 13
LT - Lituania 12
DK - Danimarca 11
NZ - Nuova Zelanda 11
BG - Bulgaria 10
HR - Croazia 10
MA - Marocco 9
MY - Malesia 9
UY - Uruguay 9
UZ - Uzbekistan 9
BO - Bolivia 8
CR - Costa Rica 8
PS - Palestinian Territory 8
GT - Guatemala 7
NI - Nicaragua 7
IQ - Iraq 6
BY - Bielorussia 5
JO - Giordania 5
LB - Libano 5
LK - Sri Lanka 5
PA - Panama 5
QA - Qatar 5
GH - Ghana 4
MK - Macedonia 4
MT - Malta 4
RE - Reunion 4
SK - Slovacchia (Repubblica Slovacca) 4
CM - Camerun 3
CU - Cuba 3
EE - Estonia 3
KE - Kenya 3
LI - Liechtenstein 3
NP - Nepal 3
SV - El Salvador 3
UG - Uganda 3
AN - Antille olandesi 2
IS - Islanda 2
MM - Myanmar 2
NE - Niger 2
PY - Paraguay 2
TG - Togo 2
AP - ???statistics.table.value.countryCode.AP??? 1
BD - Bangladesh 1
BF - Burkina Faso 1
Totale 18.525
Salva come PNG Salva come JPEG
Città #
Ann Arbor 902
Santa Clara 622
Chandler 543
Beijing 525
Fairfield 501
Dublin 385
Redwood City 380
Houston 362
Torino 361
Wilmington 333
Singapore 325
Ashburn 263
Woodbridge 239
Seattle 212
Villeurbanne 173
Cambridge 161
Jacksonville 148
Medford 136
Princeton 132
Turin 129
Pisa 121
Dearborn 108
Columbus 106
Milan 105
Nyköping 101
Tokyo 98
Warsaw 97
Guangzhou 96
Shanghai 89
Lubbock 83
Dong Ket 77
Fremont 66
Nanjing 65
Vienna 64
Bogotá 63
Jakarta 63
Madrid 59
Hangzhou 53
Helsinki 53
Santiago 53
Boston 49
Rome 49
San Diego 47
São Paulo 46
Medellín 45
Barcelona 43
New York 42
London 41
Paris 40
Buenos Aires 39
Munich 39
Lima 36
Mexico City 35
Seoul 33
Chengdu 32
Toronto 32
Los Angeles 31
Guadalajara 30
Taipei 30
Athens 27
Istanbul 26
Osaka 26
Silver Spring 26
Wuhan 26
Mexico 24
Mumbai 24
Zapopan 24
Zhengzhou 24
Ankara 23
Changsha 23
Chicago 23
Sesto San Giovanni 23
Hong Kong 22
Norwalk 22
Padova 22
Brussels 21
Ottawa 21
Jinan 20
Lisbon 20
Buffalo 19
Cuauhtémoc 19
Quito 19
Gurgaon 18
Lissone 18
Phoenix 18
Berlin 17
Hanoi 17
Kunming 17
Munro 17
Riyadh 17
Boardman 16
Caracas 16
Montreal 16
Rochester 16
Zurich 16
Bucharest 15
Hefei 15
Bangkok 14
New Delhi 14
Barranquilla 13
Totale 10.005
Salva come PNG Salva come JPEG
Nome #
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents 1.044
Acute kidney injury associated with glomerular diseases 1.035
Antiphospholipid Syndrome and the Kidney 887
Value of colchicine as treatment for recurrent oral ulcers: a systematic review 580
Central nervous system involvement in systemic lupus erythematosus: Overview on classification criteria. 565
Common variable immunodeficiency: Crossroads between infections, inflammation and autoimmunity. 528
The adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction 526
Improved (4 Plus 2) rituximab protocol for severe cases of mixed cryoglobulinemia: A 6-year observational study 524
Long-term effects of methylprednisolone pulses and mycophenolate mofetil in IgA nephropathy patients at risk of progression. 482
Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis. 470
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment 464
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 409
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study 407
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy 361
Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. 338
The role of nail-videocapillaroscopy in early diagnosis of scleroderma 304
Upcoming biological therapies in systemic lupus erythematosus. 289
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 281
Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile. 279
8-Isoprostane, prostaglandin E2, C-reactive protein and serum amyloid A as markers of inflammation and oxidative stress in antiphospholipid syndrome: a pilot study. 268
Long-term evaluation of pemphigus vulgaris: a retrospective consideration of 98 patients treated in an oral medicine unit in North-West Italy 251
Use of intravenous immunoglobulin in patients with active vasculitis associated with concomitant infection 236
Systemic AA amyloidosis as a unique manifestation of a combined mutation of TNFRSF1A and MEFV genes. 218
Rituximab in cryoglobulinemic peripheral neuropathy 206
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation 204
Antiphospholipid syndrome and relapsing polychondritis: an unusual association. 191
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents 185
Outpatient percutaneous native renal biopsy: Safety profile in a large monocentric cohort 183
Biallelic variants in the ciliary gene TMEM67 cause RHYNS syndrome 183
The prompt use of rituximab could decrease adverse effects in patient with pemphigus vulgaris: a preliminary evaluation 183
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study 175
The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab 173
Thrombotic risk assessment in antiphospholipid syndrome: The role of new antibody specificities and thrombin generation assay 168
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience 168
Chiari and Syringomyelia Consortium: a model of multidisciplinary and sharing path for rare diseases. 163
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica 162
Reliability of lupus anticoagulant and anti-phosphatidylserine/prothrombin autoantibodies in antiphospholipid syndrome: A multicenter study 156
Facilitated subcutaneous immunoglobulin treatment in pemphigus vulgaris 140
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis 135
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond 134
Filling the gap in antiphospholipid syndrome diagnosis: a patient's story 133
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience 131
Short and long-term effects of Rituximab in the treatment of severe cryoglobulinaemia with and without glomerulonephritis 125
Extemporaneous orphan drugs and preparations for rare diseases: organisation and management of an inter-regional network 122
External Quality Assurance (EQA) of Immunofixation and serum free light chain measure in 9 laboratories participating in the Piedmont and Aosta Valley consortium for systemic amyloidosis 119
First considerations on the SARS-CoV-2 epidemic in the Dialysis Units of Piedmont and Aosta Valley, Northern Italy 117
USE OF CLINICAL EXOME SEQUENCING IN THE DIAGNOSTIC FLOW OF MONOGENIC KIDNEY DISEASES: THE PIEDMONT EXPERIENCE 115
Analisi di Copy-Number Variants (CNV) e dei polimorfismi del gene C4 nelle vasculiti primitive e secondarie e nell’ artrite reumatoide. 114
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19 110
A 4 Plus 2 Infusion Protocol of Rituximab Provides Long-Term Beneficial Effects in Patients with HCV-Associated Mixed Cryoglobulinemia with Membranoproliferative Nephritis and Severe Polyneuropathy. 109
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 107
NOVEL AND KNOWN MUTATIONS IDENTIFIED BY CLINICAL EXOME SEQUENCING FOR THE DIAGNOSIS OF POLYCYSTIC KIDNEY DISEASE 103
C1 esterase inhibitor deficiency and SLE: A case report and review of the literature 97
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis 97
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso Sistemico 96
Effetti a lungo termine del rituximab nel trattamento delle forme più severe di crioglobulinemia mista HCV associata 94
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort 92
Immunological rare diseases 92
Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients 91
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 90
Anticorpo monoclonale anti CD20 nella crioglobulinemia mista 90
Syringomyelia and Chiari Syndrome Registry: advances in epidemiology, clinical phenotypes and natural history based on a North Western Italy cohort 90
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy 90
Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte-García et al 89
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature 86
OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: a case report 83
Immunotherapies in phase II and III trials for the treatment of systemic lupus erythematosus 80
Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia 77
Association between hereditary angioedema and lupus erythematosus in the mother and the son 77
Induction of remission by B lymphocyte depletion in patients with idiopathic systemic vasculitis 76
Short and long term effects on Rituximab in the treatment of severe cryoglubulinaemia with and without glomerulonephritis 74
EFFECTS OF RITUXIMAB IN THE TREATMENT OF SEVERE CRYOGLOBULINAEMIA 74
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 72
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis 72
Immunogenetics of complement in mixed cryoglobulinaemia 71
INTENSIFIED B LYMPHOCYTE DEPLETION (IBLD) WITHOUT IMMUNOSUPPRESSIVE MAINTENANCE TREATMENT AS A RESCUE THERAPY IN REFRACTORY LUPUS NEPHRITIS (LN): A 4-YEAR OBSERVATION 71
Cryoglobulinemic glomerulonephritis: Clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy 70
Anticorpo monoclonale anti CD 20 come opzione terapeutica in quadri severi di Lupus Eritematoso sistemico 68
Percorso gestionale standardizzato dalla prescrizione all'erogazione di galenici magistrali per pazienti affetti da malattie rare ed allestiti presso le farmacie ospedaliere di Piemonte e Valle d'Aosta 68
Induction of remission by B lynfocyte depletion in patients with idiopathic systemic vasculitis 66
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease 65
Alterazioni videocapillaroscopiche nella crioglobulinemia mista ocn danno renale 62
Intensified Treatment of B Lymphocyte Depletion (ITBLD) without Immunosuppressive Maintenance Treatment As a Rescue Therapy in Refractory Lupus Nephritis (LN): A 4-Year Observation 62
Piedmont and Aosta Valley Consortium of Systemic Amyloidosis: results of a four year experience 60
Piedmont and Aosta Valley inter-regional network in the context of the Italian National Network for rare diseases. 60
Improving diagnosis for rare diseases: The experience of the Italian undiagnosed Rare diseases network 60
Malattie Rare: la rete di segnalazione 59
Relationship between cryoglobulinemia-associated nephritis and HCV infection 58
Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies 57
Structural and functional properties of proteasomes purified from the human kidney 55
Purificazione e caratterizzazione di proteasomi renali umani 55
Nail fold capillaroscopy in mixed cryoglobulinaemia 55
Rare diseases in Europe: From a wide to a local perspective 55
La crioglobulinemia mista 54
Minocycline in combination with mycophenolate mofetil in oral mucous membrane pemphigoid 54
Orofacial granulomatosis’ features in a patient with a common variable immunodeficiency. 54
Terapia di induzione della remissione nelle vasculiti primitive sistemiche mediante deplezione linfocitaria B 54
Rituximab as a Therapeutic Tool in Severe Mixed Cryoglobulinemia 52
VERY LONG-TERM Effects Of The "4 PLUS2 Infusion PROTOCOL" Of Rituximabalone In Patients With HCV-Associatedmixed Cryoglobulinemia With Diffusemembranoproliferative Glomerulonephritis, Severe Polyneuropathy and Necrotic Ulcersof Skin 52
Long-term effects of Rituximab in the treatment of severe cryoglobluinaemia 50
Totale 18.486
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.862
article - articoli 0
book - libri 0
conference - conferenze 7.039
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.232 0 0 0 0 0 0 277 214 233 186 163 159
2020/20212.400 176 153 218 116 245 197 162 173 214 239 220 287
2021/20223.033 153 163 201 295 321 286 326 273 221 178 277 339
2022/20232.496 252 194 89 175 177 524 205 221 257 113 165 124
2023/20241.791 230 224 141 134 178 132 127 114 41 134 132 204
2024/20251.933 88 206 211 309 815 291 13 0 0 0 0 0
Totale 19.157